arrow
S

Sudhir Venkatesan

iqvia
H指数:17
被引数:1,770

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Assessing the association of physical distancing to avoid COVID-19 with health-related quality of life in immunocompromised adolescents: results from the cross-sectional observational EAGLE study

评估为避免COVID-19而采取的物理距离措施与免疫受损青少年健康相关生活质量之间的关联:EAGLE横断面观察研究的结果

2026-05-010
OA
Comparison of Hospitalization Costs Associated with Human Metapneumovirus and Respiratory Syncytial Virus Infection in US Adults

美国成人人类偏肺病毒与呼吸道合胞病毒感染相关的住院费用比较

2026-04-020
OAAI
Changing Prevalence of Immunocompromising Conditions in Patients Hospitalized with Severe Acute Respiratory Infection in Europe: Insights from the COVIDRIVE Study

欧洲严重急性呼吸道感染住院患者免疫抑制状况患病率的变化:COVIDRIVE研究启示

2026-03-090
OAAI
Prediction of COVID-19 hospitalisation, ICU admission or death following ChAdOx1 vaccination using artificial intelligence: A clinical predictive model from the English RAVEN study

利用人工智能预测接种ChAdOx1疫苗后COVID-19住院、ICU收治或死亡:来自英国RAVEN研究的临床预测模型

2026-02-200
PRE
Comparison of Healthcare Resource Utilization and Disease Outcomes in Adults Hospitalized with Human Metapneumovirus and Respiratory Syncytial Virus

比较因感染人偏肺病毒和呼吸道合胞病毒而住院的成年人的医疗资源利用与疾病结局

2025-12-010
OAAI
Corrigendum to ' Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study' ' [The Lancet Regional Health - Europe Vol 35 ,100747, 2024]
2024-09-010
OA
AZD1222 effectiveness against severe COVID-19 in individuals with comorbidity or frailty: The RAVEN cohort study
2024-04-014
OA
Neuraminidase Inhibitors and Hospital Length of Stay: A Meta-analysis of Individual Participant Data to Determine Treatment Effectiveness Among Patients Hospitalized With Nonfatal 2009 Pandemic Influenza A(H1N1) Virus Infection
2019-07-1728
OAAI
Impact of Outpatient Neuraminidase Inhibitor Treatment in Patients Infected With Influenza A(H1N1)pdm09 at High Risk of Hospitalization: An Individual Participant Data Metaanalysis
2017-02-1270
OAAI